{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:23:20Z","timestamp":1785032600432,"version":"3.55.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T00:00:00Z","timestamp":1387843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jhep.2013.12.021","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T08:15:23Z","timestamp":1388736923000},"page":"1075-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference"],"prefix":"10.1016","volume":"60","author":[{"given":"Stefano","family":"Fagiuoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario U.","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelista","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Toniutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.12.021_b0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cld.2012.03.014","article-title":"Is the patient a candidate for liver transplantation?","volume":"16","author":"Fox","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.mcna.2008.03.008","article-title":"Liver transplantation: indications, pretransplant evaluation, surgery, and posttransplant complications","volume":"92","author":"Koffron","year":"2008","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jhep.2013.12.021_b0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1478-3231.2004.0934.x","article-title":"Bacterial infections in cirrhosis","volume":"24","author":"Navasa","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.12.021_b0020","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.12.021_b0025","first-page":"125","article-title":"The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management","volume":"22","author":"Rubin","year":"2002","journal-title":"Curr Clin Top Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1600-6143.2006.01694.x","article-title":"Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group","volume":"7","author":"San Juan","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0035","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/lt.20199","article-title":"Selective decontamination of the digestive tract: rationale behind evidence-based use in liver transplantation","volume":"10","author":"van Saene","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(03)14409-1","article-title":"Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","volume":"362","author":"de Jonge","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.12.021_b0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/lt.22133","article-title":"Mycobacterium tuberculosis infection in liver transplantation","volume":"16","author":"Yehia","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10096-006-0182-3","article-title":"Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients","volume":"25","author":"Playford","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jhep.2013.12.021_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/13693786.2012.701765","article-title":"Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients","volume":"51","author":"Saliba","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jhep.2013.12.021_b0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/lt.23530","article-title":"Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis","volume":"18","author":"Kalil","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0891-5520(20)30327-5","article-title":"Approach to immunization in the immunosuppressed host","volume":"4","author":"Hibberd","year":"1990","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhep.2013.12.021_b0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(05)70279-8","article-title":"Vaccines for transplant recipients","volume":"15","author":"Molrine","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhep.2013.12.021_b0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1432-2277.2007.00631.x","article-title":"Immune responsiveness and protective immunity after transplantation","volume":"21","author":"Gangappa","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.12.021_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-6135.2004.00737.x","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.16.3.357-364.2003","article-title":"Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols","volume":"16","author":"Duchini","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhep.2013.12.021_b0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MOT.0b013e3283324dfc","article-title":"Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis","volume":"14","author":"Holty","year":"2009","journal-title":"Curr Opin Org Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0100","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0110","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","article-title":"Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period","volume":"83","author":"Jahng","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jhep.2013.12.021_b0120","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in solid organ transplant recipients","volume":"25","author":"Playford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2013.12.021_b0125","article-title":"Management of infections in cirrhotic patients: Report of a Consensus Conference","author":"Fagiuoli","year":"2013","journal-title":"Digestive Liver Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cld.2007.04.006","article-title":"Update in infectious diseases in liver transplant recipients","volume":"11","author":"Huprikar","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4254\/wjh.v3.i4.83","article-title":"Infections in liver transplant recipients","volume":"3","author":"Romero","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2013.12.021_b0140","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/lt.20624","article-title":"Bacterial, mycobacterial, and protozoal infections after liver transplantation \u2013 part I","volume":"11","author":"Blair","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0145","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1086\/320900","article-title":"Posttransplant microbiological surveillance","volume":"33","author":"Snydman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1399-0012.2010.01262.x","article-title":"Identifying a targeted population at high risk for infections after liver transplantation in the MELD era","volume":"25","author":"Sun","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0155","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1600-6143.2008.02304.x","article-title":"Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients","volume":"8","author":"Russell","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bpg.2012.01.004","article-title":"Risk factors for infection after liver transplantation","volume":"26","author":"van Hoek","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.12.021_b0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.idc.2010.01.005","article-title":"Infection in organ transplantation: risk factors and evolving patterns of infection","volume":"24","author":"Fishman","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhep.2013.12.021_b0170","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.12.021_b0175","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1600-6143.2009.02889.x","article-title":"Practice ASTIDCo. Donor-derived infections in solid organ transplant recipients","volume":"9","author":"Grossi","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.12095","article-title":"Practice ASTIDCo. Donor-derived infections in solid organ transplantation","volume":"13","author":"Ison","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0185","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1111\/j.1600-6143.2009.02828.x","article-title":"Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient","volume":"9","author":"Rodriguez-Hernandez","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhep.2013.12.021_b0195","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/lt.21435","article-title":"Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant","volume":"14","author":"Asensio","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/135965350701200108","article-title":"Evaluation of cytomegalovirus DNAaemia vs. pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study","volume":"12","author":"Gerna","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2013.12.021_b0205","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1600-6143.2011.03636.x","article-title":"Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation","volume":"11","author":"Gerna","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0210","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","article-title":"International consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"89","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0215","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/j.1600-6143.2008.02397.x","article-title":"Donor infection and transmission to the recipient of a solid allograft","volume":"8","author":"Len","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0220","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0225","first-page":"245","article-title":"Multicenter quality control study for human cytomegalovirus DNAemia quantification","volume":"32","author":"Lilleri","year":"2009","journal-title":"New Microbiol"},{"key":"10.1016\/j.jhep.2013.12.021_b0230","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00007890-199606150-00022","article-title":"Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors","volume":"61","author":"Grossi","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0235","unstructured":"Fryer JF, Heath AB, Anderson R, Minor PD. Collaborative study to evaluate the proposed 1st WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO ECBS, Report; 2010. p. WHO\/BS\/10.2138."},{"key":"10.1016\/j.jhep.2013.12.021_b0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3062.1999.010307.x","article-title":"Prevention and treatment of cytomegalovirus infection in organ transplant recipients","volume":"1","author":"Kusne","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0245","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0250","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0255","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0b013e3182247bb4","article-title":"Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients","volume":"92","author":"San-Juan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0265","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0270","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2013.12.021_b0275","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","article-title":"1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia","volume":"46","author":"Senn","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0280","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive aspergillosis in solid organ transplant recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1399-3062.2008.00361.x","article-title":"Outcomes of antifungal prophylaxis in high-risk liver transplant recipients","volume":"11","author":"Hadley","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0290","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.transproceed.2011.06.020","article-title":"Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients","volume":"43","author":"Grossi","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.12.021_b0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0300","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0305","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0310","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e31829d674f","article-title":"Micafungin vs. amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients","volume":"96","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0315","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/lt.23410","article-title":"Safety of anidulafungin in solid organ transplant recipients","volume":"18","author":"Aguado","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0320","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/313658","article-title":"Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients","volume":"30","author":"Singh","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.TP.0000040602.01701.85","article-title":"Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates","volume":"75","author":"Paterson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0330","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1600-6143.2009.02893.x","article-title":"Multiply resistant gram-positive bacteria: vancomycin-resistant enterococcus in solid organ transplant recipients","volume":"9","author":"Munoz","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0335","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1600-6143.2009.02890.x","article-title":"Multidrug resistant gram-negative bacteria in solid organ transplant recipients","volume":"9","author":"van Delden","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0340","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/519932","article-title":"Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients","volume":"28","author":"Ghanem","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhep.2013.12.021_b0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1399-3062.2003.00024.x","article-title":"Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial","volume":"5","author":"El-Khoury","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0350","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkh104","article-title":"Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci","volume":"53","author":"Rand","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2013.12.021_b0355","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/11317100-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of tigecycline","volume":"48","author":"Barbour","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhep.2013.12.021_b0360","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/320882","article-title":"Control of an outbreak of infection due to extended-spectrum beta-lactamase\u2013producing Escherichia coli in a liver transplantation unit","volume":"33","author":"Paterson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-3062.2011.00688.x","article-title":"Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation","volume":"14","author":"Bergamasco","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0370","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/526775","article-title":"Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline","volume":"46","author":"Anthony","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0375","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2013.12.021_b0380","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.01361-08","article-title":"Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria","volume":"53","author":"Plachouras","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2013.12.021_b0385","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1592\/phco.27.11.1490","article-title":"Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?","volume":"27","author":"Kim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhep.2013.12.021_b0390","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1111\/j.1600-6143.2009.02892.x","article-title":"Multiply resistant gram-positive bacteria methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus (MRSA, VISA, VRSA) in solid organ transplant recipients","volume":"9","author":"Garzoni","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0395","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajic.2008.03.003","article-title":"International Nosocomial Infection Control Consortium report, data summary for 2002\u20132007, issued January 2008","volume":"36","author":"Rosenthal","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jhep.2013.12.021_b0400","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/QCO.0b013e3283013add","article-title":"Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital","volume":"21","author":"Navarro","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections","volume":"42","author":"Seybold","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/lt.20338","article-title":"Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation","volume":"11","author":"Santoro-Lopes","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0415","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/500651","article-title":"Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients","volume":"27","author":"Singh","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhep.2013.12.021_b0420","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/jlts.2003.50142","article-title":"Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation","volume":"9","author":"Desai","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0425","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1517\/14656566.2011.633511","article-title":"Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia","volume":"12","author":"Rubinstein","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhep.2013.12.021_b0430","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1086\/591061","article-title":"Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals","volume":"29","author":"Calfee","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhep.2013.12.021_b0435","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1086\/498903","article-title":"Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study","volume":"42","author":"McNeil","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0440","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.transproceed.2006.08.184","article-title":"Postoperative severe pneumonia in adult liver transplant recipients","volume":"38","author":"Xia","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.12.021_b0445","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish society of infectious diseases and clinical microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0450","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nm0307-295","article-title":"From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis","volume":"13","author":"Dorman","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2013.12.021_b0455","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0460","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1600-6143.2009.02894.x","article-title":"Mycobacterium tuberculosis in solid organ transplant recipients","volume":"9","author":"Subramanian","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0465","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0470","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/605637","article-title":"Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study","volume":"49","author":"Fernandez-Sabe","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0475","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1524839909359157","article-title":"Improving foodborne illness prevention among transplant recipients","volume":"12","author":"Kosa","year":"2011","journal-title":"Health Promot Pract"},{"key":"10.1016\/j.jhep.2013.12.021_b0480","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/630201","article-title":"Strongyloidiasis in transplant patients","volume":"49","author":"Roxby","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2013.12.021_b0485","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200011093431912","article-title":"The emergence of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8)","volume":"343","author":"Moore","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.12.021_b0490","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/TP.0b013e31823104ec","article-title":"Human herpes virus 8 in solid organ transplantation","volume":"92","author":"Ariza-Heredia","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.12.021_b0495","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/j.1600-6143.2011.03769.x","article-title":"Primary and reactivated HHV8 infection and disease after liver transplantation: a prospective study","volume":"11","author":"Pietrosi","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.12.021_b0500","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.12.021_b0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/lt.20058","article-title":"Fatal disseminated Kaposi\u2019s sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients","volume":"10","author":"Marcelin","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.12.021_b0510","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1111\/j.1600-6143.2009.02896.x","article-title":"Nocardia in solid organ transplant recipients","volume":"9","author":"Clark","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813008908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813008908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T12:15:25Z","timestamp":1688904925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813008908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0168827813008908"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.12.021","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2013.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}